Perrigo (PRGO) Asset Writedowns and Impairment (2015 - 2026)

Perrigo's (PRGO) quarterly Asset Writedowns and Impairment came in at $330.8 million in Q1 2026, up 10570.97% year-on-year from N/an in Q1 2025, and down 75.65% on a QoQ basis from $1.4 billion in Q4 2025.

Perrigo (PRGO) Asset Writedowns and Impairment (2015 - 2026) Analysis & Trends

Perrigo (PRGO) has 11 years of Asset Writedowns and Impairment data on file, last reported at $330.8 million in Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment rose 10570.97% year-over-year to $330.8 million in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 1183.83% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 1433.3% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $330.8 million, down from $1.4 billion in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for PRGO reached as high as $1.4 billion in Q4 2025 and fell as low as $1.5 million in Q2 2025.
  • Historically, Asset Writedowns and Impairment has averaged $234.1 million across 4 years, with a median of $36.4 million in 2024.
  • Across the five-year window, Asset Writedowns and Impairment sank 95.6% in 2025 and surged 10570.97% in 2026, its largest moves.
  • Year by year, Asset Writedowns and Impairment stood at $90.0 million in 2023, then plunged by 57.11% to $38.6 million in 2024, then jumped by 3419.43% to $1.4 billion in 2025, then slumped by 75.65% to $330.8 million in 2026.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $330.8 million in Q1 2026, $1.4 billion in Q4 2025, and $1.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 330.80 Mn
Mar 28, 2026 330.80 Mn
Dec 31, 2025 1.36 Bn
Dec 31, 2025 1.36 Bn
Jun 28, 2025 1.50 Mn
Jun 28, 2025 1.50 Mn
Mar 29, 2025 3.10 Mn
Mar 29, 2025 3.10 Mn
Dec 31, 2024 38.60 Mn
Dec 31, 2024 38.60 Mn
Sep 28, 2024 16.20 Mn
Sep 28, 2024 16.20 Mn
Jun 29, 2024 34.10 Mn
Jun 29, 2024 34.10 Mn
Dec 31, 2023 90.00 Mn
Dec 31, 2023 90.00 Mn
Dec 31, 2021 11.00 Mn
Dec 31, 2021 11.00 Mn
Oct 2, 2021 3.50 Mn
Oct 2, 2021 3.50 Mn